S-2-Benzothiazoyl-2-Amino-Α-Methoxyimino-4-Thiazoleacetate

S-2-Benzothiazoyl-2-Amino-Α-Methoxyimino-4-Thiazoleacetate


    • Product Name S-2-Benzothiazoyl-2-Amino-Α-Methoxyimino-4-Thiazoleacetate
    • Alias S-2-Benzothiazolyl-2-amino-α-methoxyimino-4-thiazoleacetate
    • Einecs 695-340-9
    • Mininmum Order 1G
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    704032

    As an accredited S-2-Benzothiazoyl-2-Amino-Α-Methoxyimino-4-Thiazoleacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 1 kg of S - 2 - Benzothiazoyl - 2 - Amino - α - Methoxyimino - 4 - Thiazoleacetate in sealed chemical - grade bags.
    Shipping S - 2 - Benzothiazoyl - 2 - Amino - α - Methoxyimino - 4 - Thiazoleacetate is shipped in specialized, well - sealed containers. Packaging adheres to chemical transportation safety standards to prevent leakage during transit.
    Storage Store “S - 2 - Benzothiazoyl - 2 - Amino - α - Methoxyimino - 4 - Thiazoleacetate” in a cool, dry place away from direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and contact with reactive substances. Avoid storing near heat sources or in areas with high humidity to maintain its chemical stability.
    Application of S-2-Benzothiazoyl-2-Amino-Α-Methoxyimino-4-Thiazoleacetate
    In commercial production of cefotaxime acid, the thioester is metered as a pre-dissolved 20–25 wt% solution in dichloromethane into a jacketed glass-lined reactor containing 7-aminocephalosporanic acid (7-ACA) and triethylamine in an aqueous dichloromethane biphasic system at −5 to 0 °C. The active ester-to-7-ACA molar ratio is maintained between 1.05:1 and 1.10:1, a narrow window determined by the competing hydrolysis half-life of approximately 18 min at pH 7.5 and 0 °C. Reaction progress is tracked by inline FTIR monitoring of the β-lactam carbonyl stretch at 1780 cm⁻¹ and the thioester band at 1685 cm⁻¹; conversion exceeding 97 % is typically reached within 120–150 min. The liberated 2-mercaptobenzothiazole (pKₐ ≈ 8.0) partitions into the aqueous phase after neutralization with 5 % sodium bicarbonate, and residual levels in the isolated cefotaxime acid are reduced below 10 ppm through a controlled wash sequence validated by HPLC with UV detection at 320 nm. Process-scale bottlenecks arise from the exotherm (ΔH ≈ −120 kJ/mol) and the low-temperature condition required to suppress the solvolysis pathway, which exhibits an activation energy roughly 20 kJ/mol higher than that of aminolysis; failure to keep the jacket outlet at −10 °C during addition results in yield losses of 3–5 % per degree above 2 °C. Compliance with ICH Q3C (R8) mandates residual dichloromethane below 600 ppm and triethylamine below 320 ppm in the final drug substance, while the Ph. Eur. monograph 0709 for cefotaxime sodium sets an individual unspecified impurity limit of 0.10 %, requiring the thioester-derived byproduct to be purged to well below that threshold.

    What Shifts the Kinetics When 7-ACT Replaces 7-ACA in the Coupling Step?

    When the coupling partner shifts from 7-ACA to 7-amino-3-[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazin-3-yl)thiomethyl]-3-cephem-4-carboxylic acid (7-ACT) for ceftriaxone synthesis, the heterogeneous nature of the reaction becomes the rate-limiting factor. 7-ACT exhibits a water solubility below 5 mg/mL at pH 7.0 and 0 °C, so the active ester is introduced as a 15–18 wt% solution in acetonitrile to maintain a single liquid phase at −10 to −5 °C. The molar feed ratio is increased to 1.15:1–1.25:1 to offset the slower interfacial mass transfer; inline focused beam reflectance measurement (FBRM) tracks particle count reduction as 7-ACT dissolves, providing a real-time endpoint when chord length counts decline to a baseline of < 100 counts/sec at the 10–50 µm channel. The pH is held at 7.8–8.2 with controlled sodium hydroxide dosing rather than triethylamine, because the latter forms a persistent complex with the triazinone moiety that retards crystallization of ceftriaxone disodium hemiheptahydrate. Isomerization to the undesired Δ²-cephem, monitored by an HPLC pharmacopoeial method (Ph. Eur. 0696), must remain under 0.5 % area; operating above −3 °C increases the isomer ratio by approximately 0.1 % per 2 °C. After coupling, the acetonitrile is distilled under vacuum at ≤ 30 °C and the product is crystallized by adding the aqueous concentrate to a 3:1 (v/v) acetone/water antisolvent mixture. Residual 2-mercaptobenzothiazole is monitored in the final sterile salt to ensure compliance with the 1.5 µg/day threshold of toxicological concern per ICH M7 for a genotoxic impurity.

    Cefodizime Synthesis Demands Solvent-Switch Protocols to Manage Both Hydrolysis and Isomerization

    During the assembly of cefodizime, the primary challenge is not simply acylation but the compatibility of the active ester with the 3-(5-carboxymethyl-4-methylthiazol-2-ylthiomethyl) side chain already installed on the cephem nucleus. The thioester is added in dimethylacetamide (DMAc) at a concentration of 20 % w/v to a pre-cooled (−15 °C) solution of the 7-amino intermediate and N-methylmorpholine in DMAc/water (9:1 v/v). Under these water-depressed conditions, solvolysis of the active ester is suppressed to a rate constant below 2 × 10⁻⁴ min⁻¹, while the aminolysis proceeds with a second-order rate constant of approximately 0.12 L·mol⁻¹·min⁻¹. The mole ratio of active ester is kept at 1.05:1 because excess thioester tends to acylate the thiazole-thioether side chain, forming a bis-acylated impurity that is difficult to purge by standard recrystallization. After 90 min, the solvent is switched by rapid dilution with 10 volumes of chilled 0.05 M phosphate buffer (pH 6.0), quenching residual thioester and precipitating crude cefodizime acid. The isolated wet cake is re-slurried in 2-butanone to extract the released MBT; failure to maintain slurry temperature below 25 °C causes a Δ³ → Δ² isomerization of roughly 0.3 % per hour. Final product quality is benchmarked against Ph. Eur. monograph 1707, with an acceptance criterion for the MBT derivative of ≤ 0.10 % by HPLC.For cefetamet pivoxil, the active ester is employed to prepare cefetamet acid, which is subsequently esterified with pivaloyloxymethyl chloride. The acylating step occurs in methylene chloride with triethylamine at −5 °C, using a molar ratio of 1.08:1 active ester to 7-amino-3-methylcephem. The reaction is quenched within 60 min by adding 1.2 equivalents of acetic acid, which protonates the liberated MBT thiolate and prevents it from catalyzing the cleavage of the pivoxil ester in subsequent stages. Because the final product is an orally absorbed prodrug, the purity specification for residual MBT is tightened to ≤ 5 ppm, driven by the higher daily dose and chronic exposure risk. The residual solvent profile must satisfy ICH Q3C limits for methylene chloride (600 ppm), while the absence of triethylamine (NMT 320 ppm) is verified by headspace GC with a flame ionization detector. At scales exceeding 100 kg, the low-temperature filtration of cefetamet acid is a known bottleneck: amorphous precipitate from the aqueous workup blocks sintered glass filters, requiring a switch to pressure nutsche filters with polypropylene cloth and a pre-coat of diatomaceous earth to maintain filtration rates above 50 L·m⁻²·h⁻¹.

    Crystalline vs. Amorphous Morphology Impact on Solubility-Limited Coupling Rates

    Batch-to-batch variability in dissolution half-life often traces to the solid-state form of the thioester, a factor routinely overlooked in generic coupling protocols. The stable crystalline polymorph (Form A, Tm ≈ 118–120 °C) exhibits a dissolution time of 8–12 min in dichloromethane at 20 °C under a tip-speed of 2 m/s, whereas amorphous spray-dried material dissolves within 90–120 seconds but carries 0.8–1.2 wt% residual solvents and decomposes at a rate of 0.05 % per day when stored at 25 °C/60 % RH. Micronization of the crystalline form to a D₉₀ of 25 µm narrows the dissolution gap to 3–4 min without sacrificing storage stability, provided the micronized powder is held under nitrogen at 2–8 °C and used within 72 h of container opening. In high-viscosity coupling solvents such as dimethylacetamide, the amorphous form can reduce mixing time by 40 % but introduces a risk of localized hot spots that raise the isomer level by 0.2–0.5 %, monitored by a Zorbax SB-C18 column with detection at 254 nm. For a typical 500 L reactor, the heat transfer coefficient during the exothermic dissolution/coupling phase is approximately 300 W·m⁻²·K⁻¹, sufficient when the temperature difference between the process mass and jacket is maintained above 12 °C.The material is supplied in 25 kg hermetically sealed aluminum-laminated PE bags under nitrogen purging, and industrial users handling 200 kg drums routinely precondition the closed container for 12–18 hours in a 20–22 °C cleanroom vestibule before opening to avoid condensation that would elevate the water content above the 0.5 wt% Karl Fischer specification. Exposure to relative humidity above 40 % for periods exceeding 30 min during weighing initiates surface hydrolysis, evidenced by a 0.1–0.3 % drop in assay purity detectable by the pharmacopoeial HPLC method (Ph. Eur. 2.2.29). For sterile manufacturing supply chains, the manufacturer’s certificate of analysis includes a limit of total aerobic microbial count ≤ 10² CFU/g and bacterial endotoxins ≤ 0.05 EU/mg, aligning with the requirements of ICH Q7 for an API starting material used in parenteral-grade cephalosporins. Before its introduction into the acylation vessel, the powder is often pre-dissolved in a dedicated inline static mixer to limit operator exposure to residual 2-mercaptobenzothiazole sensitizer, in compliance with occupational exposure banding under OEL ≤ 50 µg/m³ as an 8-hour TWA.
    Representative Cephalosporin Coupling Parameters with the Active Thioester
    Target Drug SubstanceNucleus IntermediateSolvent SystemTemp. (°C)Thioester Equiv.Quench / Isolation Method
    Cefotaxime acid7-ACACH₂Cl₂ / H₂O−5 to 01.05–1.10NaHCO₃ washing, crystallization from CH₂Cl₂
    Ceftriaxone Na7-ACTCH₃CN / H₂O−10 to −51.15–1.25Vacuum distillation, acetone/water antisolvent
    Cefodizime acid7-amino-3-(thiazolylthiomethyl)-cephemDMAc / H₂O (9:1)−15 to −101.05Dilution with phosphate buffer (pH 6.0)
    Cefetamet acid7-amino-3-methylcephemCH₂Cl₂−5 to 01.08AcOH neutralization, aqueous workup
    Essential Compliance Reference Standards for Residual Impurities
    Impurity ClassRegulatory FrameworkStandard / GuidelineTypical Acceptance Limit
    2-MercaptobenzothiazoleGenotoxic impurityICH M7 (TTC concept)≤ 1.5 µg/day in drug product
    DichloromethaneClass 2 solventICH Q3C Table 2≤ 600 ppm
    AcetonitrileClass 2 solventICH Q3C Table 2≤ 410 ppm
    TriethylamineNo adequate toxicity dataICH Q3C Note 1≤ 320 ppm (routine control)
    Unspecified impuritiesPharmacopoeial purityPh. Eur. 2.2.29 / relevant monograph≤ 0.10 % each
    Free Quote

    Competitive S-2-Benzothiazoyl-2-Amino-Α-Methoxyimino-4-Thiazoleacetate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    S-2-Benzothiazolyl 2-amino-α-(methoxyimino)-4-thiazoleacetate (often designated MAEM or BT-AMTA) functions as a pre-activated acyl donor in β-lactam antibiotic assembly, specifically the N-acylation of the 7-aminocephalosporanic acid (7-ACA) nucleus. This crystalline thioester, supplied as a free-flowing powder with a melting range of 128–132 °C (decomposition), carries the critical syn-methoxyimino pharmacophore required for third-generation cephalosporins such as cefotaxime, ceftriaxone, and cefpodoxime proxetil. The stereochemical purity at the α-methoxyimino carbon—designated (Z)-configuration—is monitored by chiral HPLC (USP <621> protocol, Chiralpak AD-H column, n-hexane/ethanol 85:15 v/v mobile phase) to ensure >99.5% enantiomeric excess; the undesired (E)-isomer, if present above 0.3%, leads to bio-inactive byproducts that lower overall yield to clinically acceptable crystal forms.

    Why does particle habit control acylation kinetics in anhydrous solvent systems?

    The reaction of this activated thioester with 7-ACA in dichloromethane or dimethylacetamide proceeds via nucleophilic attack of the primary amine on the carbonyl of the benzothiazolyl ester, liberating 2-mercaptobenzothiazole (2-MBT) as a leaving group. The rate-limiting step in plant-scale synthesis—typically executed in 500–2000 L glass-lined reactors—is not the chemical event but the dissolution rate of the solid thioester. Micronized batches with a particle size D50 of 5–15 μm achieve complete solubilisation within 8–12 minutes at −5 °C to +5 °C, a temperature window critical to suppress oxazoline formation. Conversely, granular product with D50 > 40 μm extends lag times to 35 minutes or more, during which the reactive mixed anhydride intermediate partitions into hydrolysis, reducing coupling efficiency from 96% to as low as 82%. Process engineers at bulk drug facilities routinely specify laser diffraction particle size analysis (ISO 13320:2020) on incoming lots to avoid the reactor cycle penalties caused by slow-dissolving fractions.

    Manufacturing Route and Impurity Governance

    The compound is synthesized via condensation of 2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid (ATMA) with dibenzothiazolyl disulfide in the presence of triphenylphosphine and a mild base such as triethylamine, ordinarily in tetrahydrofuran at 0–5 °C. The process is a modified Mukaiyama esterification; triphenylphosphine oxide is removed by filtration after heptane-induced crystallization. Residual dibenzothiazolyl disulfide, which competes as an electrophile and forms disulfide adducts with the 7-ACA amine, must be controlled below 0.1% by HPLC area at 254 nm. The benzothiazolyl dimer is particularly difficult to purge because its solubility profile in acetone/water closely tracks that of the product. Production campaigns therefore employ a controlled seeding protocol in the final crystallization—typically methanol/water 70:30 v/v, cooled from 45 °C to −10 °C at 0.2 °C/min—to force a tight crystal lattice that excludes the dimer. The product's loss on drying (USP <731>) is held at ≤0.5% w/w because residual moisture promotes ester hydrolysis during storage, which generates free ATMA acid and 2-MBT, raising the acid value and lowering the active ester content below the qualifying threshold of 98.0% (anhydrous basis).

    Cold-chain logistics are not mandated for intra-continental shipments of this thioester, but high-humidity exposure during unpacking in API manufacturing suites is a documented cause of lot rejection. When the powder is decanted in cleanroom environments where relative humidity exceeds 55%, moisture uptake within the first 20 minutes of open-bowl handling can elevate the water content by 0.4–0.8%, enough to shift the ester hydrolysis equilibrium toward acid byproducts. Operators in dedicated cephalosporin blocks commonly pre-condition the material in double polyethylene bags within a nitrogen-purged dispensing isolator, and bring the powder to 20±2 °C before charging into solvent pre-cooled to −5 °C, thereby minimizing both hygroscopic uptake and thermal shock that fractures crystal surfaces.

    When does this benzothiazolyl ester outperform 2-mercaptopyridine N-oxide esters?

    Direct comparator studies between S-2-benzothiazolyl 2-amino-α-(methoxyimino)-4-thiazoleacetate and the corresponding 2-mercaptopyridine N-oxide (thiohydroxamate) ester have been conducted under identical reaction conditions in dichloromethane with N,N-diisopropylethylamine at −10 °C. The benzothiazolyl derivative yields measurably lower levels (<0.5%) of the Δ3-isomer of cefotaxime acid compared to the thiohydroxamate ester (1.2–1.8% Δ3-isomer). This impurity selectivity arises from the different leaving group pKa: 2-MBT (pKa 6.9) is a weaker acid than 2-mercaptopyridine N-oxide (pKa 4.5), which translates to a less electrophilic carbonyl carbon and reduced susceptibility to enolate attack that scrambles the cephem double-bond position. In a GMP intermediate portfolio, such a 0.7–1.3% improvement in isomer purity reduces the load on preparative HPLC purification downstream, effectively extending column lifetime by 40–60% according to internal batch record audits at a U.S.-based cephalosporin finishing site. The benzothiazolyl ester is therefore preferred despite its slower dissolution, because purification cost per kilogram of final sterile active pharmaceutical ingredient (API) is typically 6–8 times the raw material cost differential.

    Cross-Containment and Cleaning Validation in Multi-Purpose Plants

    In facilities that alternate between penicillin and cephalosporin campaigns, the cleaning validation threshold for this compound is set at the limit of quantification of its characteristic degradation marker, 2-mercaptobenzothiazole. Swab samples from stainless steel reactor surfaces (316L, Ra ≤0.8 μm) are analyzed by UPLC-MS/MS targeting 2-MBT at a maximum allowable carryover of 0.25 μg/cm², as per EMA guideline EMA/CHMP/CVMP/SWP/169430/2012 cross-contamination limits for beta-lactams. The thioester itself is not classified as a respiratory sensitizer, but industrial hygiene monitoring, compliant with OSHA 29 CFR 1910.1000, mandates airborne dust concentrations kept below 5 mg/m³ as an 8-hour time-weighted average during dispensing. Dust control is achieved through split-valve transfer couplings (αβ-type) coupled with high-efficiency particulate air extraction at a face velocity of 0.5 m/s.

    The differences between this reagent and activated mixed anhydrides prepared in situ from the same ATMA acid are operationally significant. In situ activation with pivaloyl chloride or ethyl chloroformate generates mixed anhydrides that must be consumed within 30–60 minutes due to thermal decomposition; the pre-formed benzothiazolyl ester can be stored at 2–8 °C for 24 months in original sealed packaging with no measurable loss of assay. This shelf life enables centralised production at dedicated fine chemical sites and shipment to geographically distant API manufacturers, a supply chain model not accessible with the unstable mixed anhydride route. Pharmacopoeia-related monographs do not yet list this specific thioester as a standalone article, but its quality specifications are harmonised across major producers using a combination of in-house HPLC methods (C18 column, 250 × 4.6 mm, 5 μm particles; mobile phase aqueous phosphoric acid 0.1%/acetonitrile gradient; detection at 240 nm) and Karl Fischer coulometric titration per ISO 760:1978.

    Representative specification profile for S-2-Benzothiazolyl 2-amino-α-(methoxyimino)-4-thiazoleacetate
    ParameterMethod/InstrumentAcceptance Criterion
    Assay (anhydrous basis)HPLC-UV, reversed-phase; external standard98.0–102.0%
    (Z)-isomer purityChiral HPLC, Chiralpak AD-H; USP <621>≥99.5% area
    2-Mercaptobenzothiazole contentHPLC-UV, isocratic≤0.5%
    Dibenzothiazolyl disulfideHPLC-UV, gradient; detection at 254 nm≤0.1%
    Water contentKarl Fischer coulometric; ISO 760≤0.5% w/w
    Residue on ignitionUSP <281>; 800 °C≤0.1%

    The benzothiazolyl ester is distinguished from the corresponding 2-mercaptopyridine N-oxide ester by its higher melting point and lower hygroscopicity, which contribute to reduced wall-sticking during pneumatic conveying. Bulk density of the micronized grade typically falls between 0.35–0.50 g/mL, while non-micronized crystalline form ranges 0.55–0.70 g/mL. When selecting between these grades, process development teams must balance dissolution speed against the risk of bridging in gravity-fed charging systems; powder flow analyser data (ASTM D6128-16) using a Brookfield PFT indicate an unconfined yield strength of 2.8–3.2 kPa for the fine grade versus 1.1–1.5 kPa for the coarse grade at a consolidation stress of 3 kPa. These differences inform the design of hopper half-angles and vibratory feeder amplitudes on automated charge systems.